Device Trial Radar · NCT04075591
Wavefront-guided LASIK for Monovision Treatment of Myopic Subjects With Presbyopia
Last checked: Nov 20, 2026Latest source record: Jul 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
219
Actual
Start
Sep 24, 2019
Primary completion
Jun 25, 2025
Study completion Jun 25, 2025
Sponsor
- Lead sponsor
- AMO Development, LLCNot on our public-company list
- Sponsor type
- Industry
- First posted
- Aug 30, 2019
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Other
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 40 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will be a 12-month, prospective, multicenter, open-label, non-comparative, non-randomized clinical investigation conducted at 8 to 14 sites. A total of 383 subjects will be enrolled to achieve approximately 268 treated subjects, resulting in at least 241 evaluable subjects at the point of refractive stability. After signing the informed consent, subjects meeting all inclusion and exclusion criteria in both eyes may be scheduled for surgery. The follow-up visit schedule will be the same for each operative eye.
Conditions
- Refractive Error
Interventions
iDesign Refractive Studio with STAR S4 IR® Excimer laser SystemDevice
Surgeons will perform wavefront-guided monovision LASIK for the treatment of myopic subjects with presbyopia based upon measurements obtained with an iDesign Refractive Studio.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in Driving Scale Score From Preoperative to Postoperative as Measured by Driving Scale Within Patient-Reported Outcomes With LASIK for Monovision (PROWL-M)Time frame: From preoperative (within 120 to 14 days prior to surgery on Day 0) to 12 month postoperative (operated on Day 0)
- Percentage of Participants Who Required Secondary Surgery to Reverse MonovisionTime frame: At 12 month postoperative (operated on Day 0)
Locations
10 sites in 1 country. Site status is shown where the registry gives one.
Maloney Vision Institute
Los Angeles, California
Kraff Eye Institute
Chicago, Illinois
Center for Sight
Las Vegas, Nevada
7 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.